These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

904 related items for PubMed ID: 15735016

  • 1. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC, Janz S.
    Cancer Res; 2005 Feb 15; 65(4):1306-15. PubMed ID: 15735016
    [Abstract] [Full Text] [Related]

  • 2. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.
    Park SS, Shaffer AL, Kim JS, duBois W, Potter M, Staudt LM, Janz S.
    Cancer Res; 2005 Sep 01; 65(17):7644-52. PubMed ID: 16140930
    [Abstract] [Full Text] [Related]

  • 3. Plasma cell tumour progression in iMycEmu gene-insertion mice.
    Kim JS, Han SS, Park SS, McNeil N, Janz S.
    J Pathol; 2006 May 01; 209(1):44-55. PubMed ID: 16482495
    [Abstract] [Full Text] [Related]

  • 4. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K, Borkhardt A, Wössmann W, Reiter A, Harbott J.
    Haematologica; 2004 Jul 01; 89(7):818-25. PubMed ID: 15257933
    [Abstract] [Full Text] [Related]

  • 5. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S, Quattrone A, Schiavone N, Calastretti A, Copreni E, Bevilacqua A, Canti G, Gong L, Morelli S, Nicolin A.
    Oncogene; 1996 Jul 04; 13(1):105-15. PubMed ID: 8700536
    [Abstract] [Full Text] [Related]

  • 6. Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYAC.
    Bützler C, Zou X, Popov AV, Brüggemann M.
    Oncogene; 1997 Mar 20; 14(11):1383-8. PubMed ID: 9178899
    [Abstract] [Full Text] [Related]

  • 7. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
    Fiancette R, Rouaud P, Vincent-Fabert C, Laffleur B, Magnone V, Cogné M, Denizot Y.
    J Immunol; 2011 Dec 01; 187(11):5772-82. PubMed ID: 22039300
    [Abstract] [Full Text] [Related]

  • 8. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
    Martín-Subero JI, Odero MD, Hernandez R, Cigudosa JC, Agirre X, Saez B, Sanz-García E, Ardanaz MT, Novo FJ, Gascoyne RD, Calasanz MJ, Siebert R.
    Genes Chromosomes Cancer; 2005 Aug 01; 43(4):414-23. PubMed ID: 15852472
    [Abstract] [Full Text] [Related]

  • 9. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
    Palomo C, Zou X, Nicholson IC, Bützler C, Brüggemann M.
    Cancer Res; 1999 Nov 01; 59(21):5625-8. PubMed ID: 10554044
    [Abstract] [Full Text] [Related]

  • 10. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A, Harris AW, Bath ML, Cory S.
    Nature; 1990 Nov 22; 348(6299):331-3. PubMed ID: 2250704
    [Abstract] [Full Text] [Related]

  • 11. Forward and reverse changes in Ig/myc translocation carrying tumors.
    Klein G.
    Princess Takamatsu Symp; 1989 Nov 22; 20():135-42. PubMed ID: 2562178
    [Abstract] [Full Text] [Related]

  • 12. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR, Janz S, Potter M.
    Cancer Res; 1995 Nov 01; 55(21):5012-8. PubMed ID: 7585544
    [Abstract] [Full Text] [Related]

  • 13. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D, Thomas-Tikhonenko A.
    Oncogene; 2002 Mar 14; 21(12):1922-7. PubMed ID: 11896625
    [Abstract] [Full Text] [Related]

  • 14. A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma.
    Wang HY, Bossler AD, Schaffer A, Tomczak E, DiPatri D, Frank DM, Nowell PC, Bagg A.
    Cancer Genet Cytogenet; 2007 Jan 01; 172(1):45-53. PubMed ID: 17175379
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas.
    Knezevich S, Ludkovski O, Salski C, Lestou V, Chhanabhai M, Lam W, Klasa R, Connors JM, Dyer MJ, Gascoyne RD, Horsman DE.
    Leukemia; 2005 Apr 01; 19(4):659-63. PubMed ID: 15716988
    [Abstract] [Full Text] [Related]

  • 18. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
    Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I.
    Nat Genet; 1993 Sep 01; 5(1):56-61. PubMed ID: 8220424
    [Abstract] [Full Text] [Related]

  • 19. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L, Groudine M.
    Genes Dev; 1994 Sep 15; 8(18):2212-26. PubMed ID: 7958890
    [Abstract] [Full Text] [Related]

  • 20. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
    Busch K, Keller T, Fuchs U, Yeh RF, Harbott J, Klose I, Wiemels J, Novosel A, Reiter A, Borkhardt A.
    Leukemia; 2007 Aug 15; 21(8):1739-51. PubMed ID: 17541401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.